day 1 agenda
| Day 1 (June 29, 2026) | |
| Meeting Hall-PARIOLI 2 | |
| Registrations Open (08:00-09:30) | |
| Opening Ceremony (09:30-09:45) | |
| Moderator Kosmia Loizidou, University of Cyprus, Cyprus |
|
| KEYNOTE TALKS | |
| 09:45-10:15 | Title: Impact of body mass index on the surgical outcomes and delayed adjuvant treatment in patients undergoing therapeutic mammoplasty for breast cancer |
| Maged Hussien, Norfolk and Norwich University hospital, United Kingdom | |
| 10:15-10:45 | Title: Medical research ethics with a focus on breast cancer |
| Jukka H. Meurman, University of Helsinki, Finland | |
| 10:45-11:15 | Title: Translational Bioinformatics Resources and AI Solutions for Cancer Research |
| Trupti Joshi, Marshall University, USA | |
| Group Photo 11:15-11:30 ---Refreshment Break @ Foyer |
|
| SCIENTIFIC SESSION-I Session Chair Hanna Romanska-Knight, Medical University of Lodz, Poland |
|
| Plenary Talk | |
| 11:30-11:55 | Title: A novel HER2 protein identification methodology in breast cancer cells using Raman spectroscopy and raman imaging: an analytical validation study |
| Halina Abramczyk, Lodz University of Technology, Poland | |
| 11:55-12:20 | Title: Fraction B Preparation from Catfish Skin is a Good Candidate for treating Breast Cancer Without the Use of Surgery, Radiation or Chemo Treatment and for Healing Wounds Cosmetically After Breast Cancer Surgery |
| Jassim M. H. AlMohammad Ali, Abdullah AlSalem University, Kuwait | |
| 12:20-12:40 | Title: Natural looking breast after primary reconstruction using inferior dermal flap as internal bra and submuscular silicone implant |
| Jasmina Gjorgievska Pavlovska, University Clinic of Plastic and reconstructive surgery - North Macedonia | |
| 12:40-13:00 | Title: Shaping the Future: AI-Driven Solutions in Breast Reconstruction |
| Edward Ray,Cedars-Sinai Medical Center, USA | |
| Networking & Panel Discussion | |
| 13:00-13:50 Lunch Break @ Restaurant | |
| SCIENTIFIC SESSION-II Session Chairs: Halina Abramczyk, Lodz University of Technology, Poland & Columba De La Parra, Lehman College- City University of New York, USA |
|
| 13:50-14:10 | Title: Systems-Level Reprogramming of Breast Cancer by the Traditional Chinese Medicine Formula T33: Integrating Epigenetic Regulation, Autophagy, and Tumor Evolution |
| YuTe Liu, Chung Shan Medical University, Taiwan | |
| 14:10-14:30 | Title: PTEN inactivating mutations are associated with hormone receptor loss during breast cancer recurrence |
| Haiying Zhan, Yale University, USA | |
| 14:30-14:50 | Title: RET Receptor Tyrosine Kinase Promotes Breast Cancer Metastasis to the Brain and RET Inhibitors Pralsetinib and Selpercatinib Suppress Breast Cancer Brain Metastases |
| Hui-Wen Lo, Texas A&M University Naresh K. Vashisht College of Medine, USA | |
| 14:50-15:10 | Title: Mechanisms of Action of FDA-Approved Endocrine Therapies for ER-Positive Breast Cancer |
| Kiven Erique Lukong, University of Saskatchewan, Canada | |
| 15:10-15:30 | Title: DCIS-associated myoepithelial cells create a pro-tumorigenic microenvironment through up-regulation of integrin αvβ6 |
| J Louise Jones, Queen Mary University of London, UK | |
| 15:30-15:50 | Title: FGF/FGFR-Signalling in triple-positive breast cancer: molecular subtyping in aid of disease prognostication |
| Hanna Romanska-Knight, Medical University of Lodz, Poland | |
| 15:50-16:00 Refreshment Break | |
| 16:00-16:20 | Title:Proteomics Approaches in Discovery of Potential Enzymatic Biomarkers for Early Diagnosis of Breast Cancer |
| Zoran Minic, University of Ottawa, Canada | |
| 16:20-16:40 | Title: Targeting Tumor-Associated Hydroxyapatite to Disrupt Tumor Metabolism: A Novel Therapeutic Strategy for Breast Cancer Using Nanodrugs |
| Mohammed Noor Tantawy, Vanderbilt University Medical Center, USA | |
| 16:40-17:00 | Title: Identification and Therapeutic Targeting of Tumor-initiating Cells in Triple-negative Breast Cancer (TNBC) |
| Michael T. Lewis, Baylor College of Medicine, USA | |
| Networking & Panel Discussion | |
| Day-1 Concludes | |
day 2 agenda
| Day 2 (June 30th, 2026) | |
| Meeting Hall-PARIOLI 2 | |
| Moderator Hui-Wen Lo, Texas A&M University Naresh K. Vashisht College of Medine, USA |
|
| KEYNOTE TALKS | |
| 09:30-10:00 | Title: Breast Cancer Diagnosis using Subtraction of Temporally Sequential Digital Mammograms |
| Kosmia Loizidou, University of Cyprus, Cyprus | |
| 10:00-10:30 | Title: Crosstalk Between Metabolism and Translation in Highly Metastatic Triple-Negative Breast Cancer (TNBC) |
| Columba De La Parra, Lehman College- City University of New York, USA | |
| 10:30-11:00 | Title: The Luminous Pro Series, Pink Luminous Breast, an LED based technology utilizing patented red light wavelengths between 640 to 800 nanometers, has demonstrated comparable sensitivity and specificity to mammography in detecting breast abnormalities |
| Marylin R Dans, U R Luminous, USA | |
| 11:00-11:15 ---Refreshment Break @ Foyer | |
| SPEAKER PRESENTATIONS | |
| SCIENTIFIC SESSION-III Session Chairs Amy S Yee, Tufts University School of Medicine, New Orleans (LSUHSC-NO), USA & Mohammed Musa Yahya Alzahrani, Imam Mohammad Bin Saud Islamic University, Saudi Arabia |
|
| 11:15-11:35 | Title: Caspase Activation, Upregulation of Bax and P53, Downregulation of Bcl-2 and Enhanced Generation of Reactive Oxygen Species Mediate the Anti-proliferative and Anti-migratory Activity of Mefenamic Acid in Breast Cancer Cellss |
| Mohammed Musa Yahya Alzahrani, Imam Mohammad Bin Saud Islamic University, Saudi Arabia | |
| 11:35-11:55 | Title: Pain and Lymphedema Characteristics of Women with Breast Cancer-Related Lymphedema with and without Type 2 Diabetes Mellitus |
| Esra Uzelpasaci, University of Health Sciences, Turkey | |
| 11:55-12:15 | Title: CHA1: An Epigenetics-Plus Combinatorial Therapy That Enables Immune Checkpoint Susceptibility with Epigenetic Disruption |
| Amy S Yee, Tufts University School of Medicine, New Orleans (LSUHSC-NO), USA | |
| 12:15-12:35 | Title: Deep learning and transfer learning identify breast cancer survival subtypes from single-cell imaging data |
| Lana Garmire, University of Alabama at Birmingham, USA | |
| 12:35-12:55 | Title: Iron Status Across the Menopausal Transition: A Dual Mechanism Driving Breast Cancer Incidence and Recurrence |
| Makfire Ajeti, Anglia Ruskin University, Turkey | |
| 12:55 -1:55 Lunch @ Restaurant | |
| Conference Concludes | |
Virtual agenda
| Day 2 (June 30, 2026)-Virtual Presentations | |
Time Zone: Central European Time (CET) |
|
| 10:40-11:00 | Title: Breast Cancer Survivorship: Lived Experiences of Challenges and Accessing Support for Psychological Distress |
| Syeda Zakia Hossain, University of Sydney, Australia | |
| 11:00-11:20 | Title: Knowledge Mapping of Global Trends in DNA Damage Repair-related Breast Cancer Research: A Bibliometric Study |
| Yajing Huang, Second Affiliated Hospital, School of Medicine, Zhejiang University, China | |
| 11:20-11:40 | Title: Association between adjuvant chemotherapy and outcomes after resection of locoregional recurrence in hormone receptor–positive HER2-negative breast cancer: a multi-institutional retrospective study |
| Yukinori Ozaki, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Japan | |
| 11:40-12:00 | Title: Real time App Deployment: Analysis of Image for Breast Cancer Detection using Feature-Rich Deep Learning Architecture |
| Pinki Roy, National Institute of Technology Silchar, India | |
| 12:00-12:20 | Title: Mutation analysis in investigating the status of genes associated with homologous recombinant repair in hormone receptor-positive breast cancer |
| Tekincan Cagr? Aktas, Ege University Faculty of Medicine, Turkey | |
| 12:20-12:40 | Title: Dissecting Notch-driven EMT programs at single-cell resolution in breast cancer |
| Magdalena Orzechowska, Medical University of Lodz, Poland | |
| 12:40-13:00 | Title: Understanding Chemo-Brain: Is Exercise a Pathway to Cognitive Health in Breast Cancer Survivorship? |
| Ozgu Inal Ozun, University of Health Sciences, Turkey | |
| 13:00-13:20 | Title: Immunomodulating and antiproliferative effects of novel N-chalconyl im-idazolidones in breast cancer models |
| Atziri Corin Chavez Alvarez, Université Clermont-Auvergne, France | |
| 13:20-13:30 | Title: Expression of PD-L1, IRF1 and CD8 T Lymphocyte Infiltration in a Primary Subset of Breast Cancer Patients in Sudan |
| Shahenaz Shaban Salih Mohamed Nour,Sudan University of Science and Technology, Sudan | |
| 13:30-13:50 | Title: HER2 amplification by next-generation sequencing to identify her2-positive invasive breast cancer with negative her2 immunohistochemistry |
| Ying S. Zou, The Johns Hopkins University, USA | |
| 13:50-14:10 | Title: Relationship between diagnostic characteristics, lifestyle habits and breast cancer subtypes in women |
| Fernanda Cristina Marin, Escola de Enfermagem da Universidade de São Paulo, Brazil | |
| 14:10-14:30 | Title: The Prognostic Utility of Perioperative Blood-based Liquid Biopsy in Patients with Non-metastatic Breast Cancer |
| Fara Hassan, Cork University Hospital, Ireland | |
| 14:30-14:50 | Title: The Causal Effect of Physical Activity in Adulthood on Breast Cancer Risk Among Polish Migrant Women in US |
| Azam Najaf Kouchak, Michigan State University, USA | |
| 14:50-15:10 | Title: A Case of Grade II Breast Mucinous Carcinoma Progression from Ductal Carcinoma in Situ |
| Clara Straus, St. John's Episcopal Hospital, USA | |
| 15:10-15:30 | Title: Dose-Dependent Mitochondrial Reprogramming by Biguanides Antagonistically Regulates c-Src–Driven Tumor Progression |
| Benny Abraham Kaipparettu, Baylor College of Medicine, USA | |
| 15:30-15:50 | Title: Beyond Cancer: BRCA as Guardians of Cardiovascular Homeostasis |
| Krishna Singh, Western University London, Canada | |
| 15:50-16:10 | Title: Prospective study of emergency medicine provider wellness across ten academic and community hospitals during the initial surge of the COVID-19 pandemic |
| Kelker Heather, Riley Hospital for Children at Indiana Unversity Health, USA | |
| 16:10-16:30 | Title: Exercise as Medicine in Cardio-Oncology: Reducing Health Disparities in Hispanic and Latina Breast Cancer Survivors |
| Christina M. Dieli-Conwright, Harvard Medical School, USA | |
| 16:30-16:50 | Title: Combining PARP and FEN1/EXO1 inhibition in triple-negative breast cancer |
| Saima Hassan, University of Montreal, Canada | |
| 16:50-17:10 | Title: Rare Breast Cancers Review |
| Harnoor Singh, University of Texas at Houston, USA | |
| 17:10-17:30 | Title: Developing novel endocrine therapy controlling both estradiol and DHT against ER+ breast cancer |
| Sheng-Xiang Lin, Centre de recherche du CHU et Université Laval, Canada | |
| 17:30-17:50 | Title: Estimating the Lifetime Risk of Breast Cancer With and Without a Screening History |
| Dongfeng Wu, University of Louisville, USA | |
| 17:50-18:10 | Title: A novel method of finding non-infectious disease causes by combining multiple research and results of its application: A unique combination of physiological changes which causes Breast Cancer |
| Alan Olan, Independent Researcher, USA | |
| 18:10-18:30 | Title: Transgender breast imaging: current practice, challenges and future directions |
| Jamie Spoont, University of Miami Miller School of Medicine, USA | |
| 18:30-18:50 | Title: Molecular testing and targeting for solid tumors with CNS metastases |
| Toni Cao, Stanford University School of Medicine, USA | |
| 18:50-19:10 | Title: Leronlimab is associated with long-term survival in metastatic triple-negative breast cancer (mTNBC) potentially enhancing PD-L1 expression, and ICI response |
| Richard G Pestell, The Baruch S Blumberg Institute, USA | |
| 19:10-19:30 | Title: Recent progress on optical imaging for intraoperative assessment of tumor margins during lumpectomy |
| Bing Yu, Marquette University and Medical College of Wisconsin, USA | |
| 19:30-19:50 | Title: Quercetin targets TGFb-primed human MDA-MB-231 triple-negative breast cancer cells, linking epithelial-mesenchymal transition to cell senescence and fibrosis |
| Borhane Annabi, Université du Québec à Montréal, Canada | |
| 19:50-20:10 | Title: Integrated in vitro and in silico analysis of pomegranate-derived polyphenols targeting novel variants in MCF-7 breast cancer cells |
| Anum Munir, The London College UCK, UK | |
| Closing Ceremany | |
| Note: This is the tentative program only and the timings may be subject to change | |
| If any one interested to attend the conference or to book your speaker slot, please send an email to breastcancer@innovinc.org | |